New Mayne Pharma CEO Starts Today, page-5

Raj he shouldn’t get anything. I have only now read
with more detail the EY. Auditors report. LTI would
remember our association and agreement with
“Hedgepath” the owners of R and D for Suba- Intracozole
I remember them starting legal action against Mayne
which Richards brushed off as nothing to worry about.
They were cash poor but had a great product going
through FDA approval. We ( Mayne Pharma ) kept
the money supplied to Hedgepath. Generally in US $4m
allotments. Their action began in 2019 then in November
21 an in principle agreement was reached. This took a
further 7 months and final settlement not until December
this year. Our insurance Company has agreed to US $14+m. Obviously we lost the case and it appears the
product even though we owned majority of the company.
Honestly, can you believe this guy . This settlement was
confidential. Now I am concerned regarding future legal
matters . DOJ ! Class Action here in Australia. The
rats are all jumping ship. ( including past board members).